Nimble aims to be the leading global collaborator in delivering actionable intelligence from the GI tract.
Follow our journey   

A Message from Our Founders " 2025 has been a defining year for Nimble Science. Together with our partners and clients, we’ve advanced the boundaries of GI health research, transforming curiosity into clinical and commercial impact. Thank you for your continued trust and collaboration. " Sabina & Joseph, Co-Founders, Nimble Science 2025 Highlights Regulatory Progress Health Canada Class II Medical Devi

CALGARY, AB — September 3, 2025 — Nimble Science, a precision medicine company with a cutting-edge data platform, announced today that it has received a Medical Device Licence from Health Canada for its SIMBA™ Capsule. This ingestible device is the first to collect targeted and preserved fluid samples from the small intestine for physiological assessment. The approval designates the SIMBA Capsule as a Class II medical device, marking a significant milestone for the company an

Nimble Science and KGK Science have signed a Letter of Intent to leverage their expertise and product offerings to build a stronger...

Calgary, Canada – January 28, 2025 Nimble Science, the pioneer of enabling at-home intestinal fluid biopsies, announced today the...

Copenhagen, Denmark – January 21, 2025 Cmbio ™ , a global leader in multi-omics science and digital biology, announces a strategic...

Calgary, January 9, 2025 - Nimble Science, a precision medicine company empowering biopharma and digestive health companies with access...

Lallemand Health Solutions in collaboration with Nimble Science Ltd. and Dr. Eamon Quigley from Houston Methodist, Dr. Jens Walter from...

You can access the full publication in Frontiers here . The Rosell® Institute for Microbiome and Probiotics, in collaboration with Nimble...